A. Zubia

Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study.

F. Cossío, C. Masdeu, A. Rodríguez-Gascón, 2015, Biomedical chromatography : BMC.

Solvent-free thermal and microwave-assisted [3 + 2] cycloadditions between stabilized azomethine ylides and nitrostyrenes. An experimental and theoretical study.

M. Herrero, A. de la Hoz, Á. Díaz‐Ortiz, 2007, The Journal of organic chemistry.

Application of stereocontrolled stepwise [3+2] cycloadditions to the preparation of inhibitors of alpha4beta1-integrin-mediated hepatic melanoma metastasis.

A. Arrieta, F. Cossío, F. Vidal-Vanaclocha, 2005, Angewandte Chemie.

Quantitative evaluation of the catalytic activity of dendrimers with only one active center at the core: application to the nitroaldol (Henry) reaction.

Iñaki Morao, X. López, F. Cossío, 2004, Journal of the American Chemical Society.

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma

E. González-Barca, F. Setién, M. Esteller, 2018, Haematologica.

Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity

M. Fraga, E. Ballestar, S. Ropero, 2009, Oncogene.

Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice

José Luis Pedraz, Fernando P. Cossío, J. Pedraz, 2009, Cancer Chemotherapy and Pharmacology.

Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of Kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: application to a pharmacokinetic study.

J. Pedraz, F. Cossío, A. Rodríguez-Gascón, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development.

R. Stote, X. López, D. Pantoja-Uceda, 2013, Journal of medicinal chemistry.

(2S*,3R*,4S*,5R*)‐3‐(S*‐1‐Benzyl­oxy­ethyl)‐4‐methyl‐4‐nitro‐5‐phenyl­proline methyl ester

A. Linden, A. Arrieta, F. Cossío, 2001 .